Menu
Deep Knowledge Group · Investment

Investment, Technology & Knowledge Assets

Deep Knowledge Group invests in publicly traded companies, private technology businesses and the Group’s own commercial platforms. Since its first longevity investment in 2014, DKG has combined capital with scientific intelligence, technology development and the acquisition of intellectual property and knowledge assets.

2014Deep Knowledge Ventures founded
Data-ledOpportunity identification and due diligence
FrontierDeepTech, BioTech, QuantumTech and related domains
ActiveStrategy, networks, analytics and operating support
Investment Thesis

A continuous system from deep knowledge to technology assets

Years of scientific and industrial profiling, extensive ecosystem databases and proprietary analytical methods provide the knowledge required for selective investment, technology acquisition and practical deployment.

  1. 01 · Analytical foundations

    Frameworks, classification and benchmarking

    Develop the taxonomies, analytical methods and readiness criteria that make a frontier domain comparable and intelligible.

    Industry frameworks ↗
  2. 02 · Ecosystem intelligence

    Map and profile whole ecosystems

    Build extensive structured databases linking technologies, organisations, investors, institutions, infrastructure and expertise.

    Ecosystem mapping ↗
  3. 03 · Decision infrastructure

    Proprietary analytics and forecasting

    Translate those databases into big-data analytics, investment intelligence and dashboards for internal use and commercial applications.

    Analytics and dashboards ↗
  4. 04 · Assets and deployment

    Develop, acquire and deploy

    Use that knowledge to select technology and IP, build projects and spinouts, and bring practical capabilities into real-world use.

    Projects and priority domains ↗
Public-market portfolio

Selected publicly traded companies

Insilico Medicine and BTQ illustrate DKG’s early investment in longevity, AI-enabled biotechnology and QuantumTech. Both subsequently became publicly traded, connecting the Group’s long-term technology focus with public-market milestones.

Insilico Medicine Hong Kong Stock Exchange listing photograph supplied for this page
Insilico Medicine
Seed Investment · 2014

Insilico Medicine

DKG, through Deep Knowledge Ventures, provided seed funding in 2014. This was the Group’s inaugural longevity investment. Insilico Medicine listed in Hong Kong on 30 December 2025, with the largest Hong Kong biotech IPO of that year by funds raised. The investment is a public-market milestone for DKG’s early focus on longevity and AI-enabled biotechnology.

Later financing and IPO participation

Investors included Warburg Pincus, HongShan, Qiming Venture Partners, Hillhouse, Eight Roads, Lilly Asia Ventures, OrbiMed, Tencent, Temasek Holdings, Prosperity7 and WuXi AppTec.

BTQ stock-exchange photograph supplied for this page
BTQ Technologies
Quantum Technology

BTQ Technologies Corp.

Deep Knowledge Ventures invested in BTQ while it was privately held. BTQ later became publicly traded, providing a public-market reference for the Group’s early positioning in quantum technology and post-quantum cybersecurity.

Private-company investment

Frontier technology in private markets

OffWorld autonomous mining robots operating in an underground mine
AI robotics · Industrial autonomy

OffWorld

DKG has invested in OffWorld, a privately held company developing AI-enabled autonomous robotic systems for mining and other demanding environments.

Its modular robots combine advanced controls with specialist excavation tools. The company’s technology programme spans terrestrial mining, industrial applications and the emerging lunar economy.

Explore OffWorld →
Deep Intelligence Before Capital

A proprietary intelligence stack turns complexity into asymmetric strategic advantage

Ecosystem DataCompanies, investors, technologies, markets, institutions and people.
Scientific IntelligenceMechanisms, evidence, expert networks, technology maturity and validation.
Market & Investment AnalyticsBenchmarking, thematic dashboards, opportunity mapping and risk context.
Strategic DecisionInvestment, partnership, venture build, market entry or no-go.
Investment Intelligence

Decision infrastructure before capital allocation

Illustrative ecosystem intelligence and technology deployment
Ecosystem intelligence connects evidence, valuation and deployment.
Analytics as an Investment Asset

Market intelligence is not a side product

The Group’s analytics and dashboard infrastructure supports its own investment process and is also productised for investors, corporations and institutions.

Ways to Engage

Technology, IP and knowledge-asset collaboration

Technology owners

Technology and IP acquisition

Evidence, ownership or licensing position, development stage and a clear route to practical use.

Developers

Joint development and spinouts

Technology assets and specialist capabilities that can strengthen or extend the Group’s own programmes.

Institutions

Strategic intelligence

Analytical frameworks, ecosystem mapping, benchmarking and forecasting for defined technology and capital decisions.

Operators

Platform and deployment partnerships

Integration, productization and implementation of frontier technologies in real operating environments.

Discuss technology, intellectual property or a deployment partnership

Share the asset or capability, its evidence base, and the proposed acquisition, licensing or co-development route.

Partner With Us →
This page is a corporate overview, not an offer to sell securities or a solicitation to invest. AUM, investment amounts and ownership percentages are not publicly disclosed.